| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/31/2006 | US7129048 Identifying preferential nucleotide sequences using coded microcrystal microarrays; gene pattern expression analysis; semiconductors and bioassays |
| 10/31/2006 | US7129046 Linking to chemical array assemblies with metal layers |
| 10/31/2006 | US7129045 Methods of detecting polynucleotide kinase and its use as a label |
| 10/31/2006 | US7129040 identification, on human chromosome 10, of a tumor suppressor gene. Defects in this gene are associated with the development of cancers, such as gliomas |
| 10/31/2006 | US7129039 Unique dendritic cell-associated C-type lectins, dectin-1 and dectin-2; compositions and uses thereof |
| 10/31/2006 | US7129038 Using permeable sheets for monitoring and measuring glucose, cholesterol, protein and/or phenylalanine concentrations in bodily fluids; colorimetric analysis |
| 10/31/2006 | US7129037 Delivering antigen to dendritic cells by contacting dendritic cells with apopototic cells expressing an antigen to allow antigen to be internalized by the dendritic cells, and wherein apoptotic cells have been induced in vitro to become apoptotic |
| 10/31/2006 | US7129036 Reporter molecules and methods for assaying the lipidations status of a cell |
| 10/31/2006 | US7128912 Fibronectin binding protein compositions and methods of use |
| 10/31/2006 | US7128904 Material containing metal ion ligand complex producing nitric oxide in contact with blood |
| 10/31/2006 | US7128877 Methods and devices for obtaining and assaying mammary fluid samples for evaluating breast diseases, including cancer |
| 10/31/2006 | US7128875 Signal processing devices comprising biological and bio-mimetic components |
| 10/31/2006 | US7128393 Highly parallel fabrication of microarrays by ink jet printheads |
| 10/31/2006 | US7128265 Orientation determination |
| 10/31/2006 | US7127958 Dust testing facility for motor vehicles |
| 10/31/2006 | US7127951 Roll firmness measuring system and process |
| 10/31/2006 | US7127935 Wireless gas composition sensor system |
| 10/31/2006 | CA2420149C Dry powder formulation for protein labeling |
| 10/31/2006 | CA2336561C Monoclonal antibody to lymphocyte-associated cell surface protein |
| 10/31/2006 | CA2332183C Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (egf-r); diagnostic and therapeutic use |
| 10/31/2006 | CA2311550C Method and equipment for controlling properties of paper |
| 10/31/2006 | CA2256545C Probe for analysis of nucleic acids |
| 10/31/2006 | CA2250047C Monoclonal antibodies binding human growth hormone (hgh) |
| 10/31/2006 | CA2239729C Cell separation composition, kit and method |
| 10/31/2006 | CA2230672C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 10/31/2006 | CA2180830C Anti-annexin-v monoclonal antibody, process for producing the same, and use thereof |
| 10/31/2006 | CA2162677C Expression of ntrk1-derived oncogenes in pc12 pheochromocytoma cells and use thereof for the screening of anti-tyrosine kinase compounds |
| 10/31/2006 | CA2129733C Mammalian expression systems for hcv proteins |
| 10/28/2006 | CA2545188A1 Electrochemical-based analytical test strip with hydrophilicity enhanced metal electrodes |
| 10/28/2006 | CA2545179A1 Method for manufacturing an electrochemical-based analytical test strip with hydrophilicity enhanced metal electrodes |
| 10/28/2006 | CA2544997A1 Immobilized biological material with improved functionality and method for producing the same |
| 10/28/2006 | CA2544140A1 Method and system for screening lubricating oil compositions |
| 10/26/2006 | WO2006113930A2 Device for rapid detection and identification of single microoganisms without preliminary growth |
| 10/26/2006 | WO2006113915A2 Ultrasensitive detection of prions by automated protein misfolding cyclic amplification |
| 10/26/2006 | WO2006113880A2 Intact igfbp-3 as a colon cancer risk factor in patients with inflammatory bowel disease |
| 10/26/2006 | WO2006113832A2 System and method for predicting mold growth in an environment |
| 10/26/2006 | WO2006113803A2 Methods of determining dispersant-containing contamination of pigment and mineral products |
| 10/26/2006 | WO2006113747A2 Diagnostic markers of breast cancer treatment and progression and methods of use thereof |
| 10/26/2006 | WO2006113727A2 Fluidic structures including meandering and wide channels |
| 10/26/2006 | WO2006113723A2 Compositions and methods for diagnosing, predicting therapeutic response of, and monitoring autoimmune disease |
| 10/26/2006 | WO2006113720A2 Solid phase immobilization of phospholipids and cofactor proteins via covalent attachment |
| 10/26/2006 | WO2006113703A2 Carboline derivatives useful in the treatment of cancer |
| 10/26/2006 | WO2006113559A2 Methods for modulating bone formation and mineralization by modulating krc activity |
| 10/26/2006 | WO2006113529A2 Diagnosis of sepsis |
| 10/26/2006 | WO2006113477A2 Use of phosphonazo iii for the measurement of calcium, magnesium and sodium in analytical samples |
| 10/26/2006 | WO2006113440A2 Multi-transduction mechanism based microfluidic analyte sensors |
| 10/26/2006 | WO2006113352A2 Implantable biosensor comprising transgenic mammalian cells |
| 10/26/2006 | WO2006113289A2 Saposin d and fam3c are biomarkers for alzheimer's disease |
| 10/26/2006 | WO2006113251A2 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
| 10/26/2006 | WO2006113245A2 Methods for measuring glycan levels of proteins |
| 10/26/2006 | WO2006113237A2 Cd39l3 and its role in diabetes |
| 10/26/2006 | WO2006113210A2 Diagnostic multimarker serological profiling |
| 10/26/2006 | WO2006113139A2 Method of altering the binding specificity of proteins by oxidation-reduction reactions |
| 10/26/2006 | WO2006113089A2 Diagnosis by determination of hyperactivity or increased expression of members of cell signaling pathways |
| 10/26/2006 | WO2006113050A2 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways |
| 10/26/2006 | WO2006113032A1 Method for imaging an array of microspheres |
| 10/26/2006 | WO2006112962A2 Syphilis diagnostic test and kits |
| 10/26/2006 | WO2006112915A1 Wireless acoustic oil filter sensor |
| 10/26/2006 | WO2006112900A1 System and method for promoting oral health |
| 10/26/2006 | WO2006112827A1 Rapid analysis of functional fluids |
| 10/26/2006 | WO2006112777A2 Uses of rhcc in drug delivery, real filtering, chemical catalysis and production of nanoparticles |
| 10/26/2006 | WO2006112771A1 Magnetic beads |
| 10/26/2006 | WO2006112738A1 Novel peptides and methods for the treatment of inflammatory disorders |
| 10/26/2006 | WO2006112708A1 Immobilisation of antigenic carbohydrates to support detection of pathogenic micro-organisms. |
| 10/26/2006 | WO2006112551A2 A THERAPEUTIC AGENT FOR Aβ RELATED DISORDERS |
| 10/26/2006 | WO2006112550A2 A THERAPEUTIC AGENT FOR Aβ RELATED DISORDERS |
| 10/26/2006 | WO2006112513A1 Method and composition to evaluate cytochrome p450 2d6 isoenzyme activity using a breath test |
| 10/26/2006 | WO2006112482A1 Prediction of prognosis of liver disease associated with hepatitis c virus infection |
| 10/26/2006 | WO2006112456A1 Perkinson disease-related gene grk5 and use thereof |
| 10/26/2006 | WO2006112449A1 NOVEL NON-HUMAN ANIMAL MODEL FOR ALZHEIMER'S DISEASE HAVING DETERIORATED A-β EXCRETION FUNCTION |
| 10/26/2006 | WO2006112445A1 Immunochemical determination method and determination reagent for cytochrome c |
| 10/26/2006 | WO2006112418A1 Screening system for substance inhibiting inflammatory change of adipocyte and screening method using the same |
| 10/26/2006 | WO2006112400A1 Method of examining metastatic property and infiltration ability of cancer |
| 10/26/2006 | WO2006112339A1 Method for determination of hemoglobin derivative, and reagent composition, assay kit, analysis device and analysis system for use in the method |
| 10/26/2006 | WO2006112238A1 Gene capable of controlling differentiation/growth of plant, and use of the same |
| 10/26/2006 | WO2006111986A1 Method for the detection and the isolation of immunosuppressive regulatory t cells and uses thereof |
| 10/26/2006 | WO2006111758A1 Method of determining the point at which coagulating blood forms a clot |
| 10/26/2006 | WO2006111741A1 A method of measuring the glomerular filtration rate of a human or animal patient, a self-use kit for providing blood samples for use in measuring the glomerular filtration rate of a patient, and a method of collecting timed samples of capillary blood from a patient |
| 10/26/2006 | WO2006111726A1 Water soluble fluoro-substituted cyanine dyes as reactive fluorescence labelling reagents |
| 10/26/2006 | WO2006111711A1 A method for producing a nitrogen functionalised surface |
| 10/26/2006 | WO2006111559A1 Device and method for ultrasonically determining the dynamic elastic modulus of a material |
| 10/26/2006 | WO2006111550A2 Method using an electrochemical sensor and electrodes forming said sensor |
| 10/26/2006 | WO2006111424A1 Methods for identifying modulators of cb1 and cb2 cannabinoid receptors and their use in wound healing |
| 10/26/2006 | WO2006111355A1 Compositions for the prevention and the treatment of pain comprising phosphatidylethanolamine-binding protein (pebp) derived molecules |
| 10/26/2006 | WO2006111325A1 Microoptical detection system and method for determining analyte temperature-dependent parameters |
| 10/26/2006 | WO2006111082A1 A device for real-time and continuous monitoring gel electrophoresis and method thereof |
| 10/26/2006 | WO2006111035A1 Method for the identification of possibly harmful receptor tyrosine kinase (rtk) mutations and of inhibitors or medication directed against rtk mutantstitle |
| 10/26/2006 | WO2006111029A1 Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers |
| 10/26/2006 | WO2006111028A1 Pcr for mrsa sccmec typing |
| 10/26/2006 | WO2006110963A1 Monitoring of the v1sco-elastic properties of gels and liquids |
| 10/26/2006 | WO2006110950A1 In vivo model for preclinical drug development |
| 10/26/2006 | WO2006110940A1 Biomarker for growth hormone |
| 10/26/2006 | WO2006110939A1 Detection of endoparasites in herbivores |
| 10/26/2006 | WO2006094375A9 Correction for temperature dependence of assays |
| 10/26/2006 | WO2006089697B1 Method for determining the total coagulation activity of a blood or plasma sample |
| 10/26/2006 | WO2006086995A9 Electric conductors, fermentation catalysis and chemical analysis devices |
| 10/26/2006 | WO2006085984A9 Immune cell biosensors and methods of using same |
| 10/26/2006 | WO2006085897A3 Microfluidic device and leucocyte antigen mediated microfluidic assay |
| 10/26/2006 | WO2006084694A3 Use of the mcm8 gene for the preparation of a pharmaceutical composition |
| 10/26/2006 | WO2006076905A3 Method for detecting and removing endotoxin |